Lisa E. Gralinski

About Lisa E. Gralinski

Lisa E. Gralinski, With an exceptional h-index of 50 and a recent h-index of 45 (since 2020), a distinguished researcher at University of North Carolina at Chapel Hill, specializes in the field of virology, coronavirus pathogenesis, mouse models of disease, respiratory disease.

His recent articles reflect a diverse array of research interests and contributions to the field:

Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies

Understanding COVID-19-associated coagulopathy

Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses

A multitrait locus regulates sarbecovirus pathogenesis

SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice

Spatial Transcriptional Profiling of Chronic Pulmonary Disease in a Mouse-Adapted Model of SARS-CoV-2

Lisa E. Gralinski Information

University

Position

Department of Epidemiology

Citations(all)

18870

Citations(since 2020)

16828

Cited By

8891

hIndex(all)

50

hIndex(since 2020)

45

i10Index(all)

75

i10Index(since 2020)

72

Email

University Profile Page

Google Scholar

Lisa E. Gralinski Skills & Research Interests

virology

coronavirus pathogenesis

mouse models of disease

respiratory disease

Top articles of Lisa E. Gralinski

Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans

Virus Research

2024/6/1

Broadly neutralizing anti-S2 antibodies protect against all three human betacoronaviruses that cause deadly disease

Immunity

2023/3/14

A model of persistent post SARS-CoV-2 induced lung disease for target identification and testing of therapeutic strategies

BioRxiv

2022/2/15

Understanding COVID-19-associated coagulopathy

2022/10

Targeted isolation of diverse human protective broadly neutralizing antibodies against SARS-like viruses

Nature immunology

2022/6

A multitrait locus regulates sarbecovirus pathogenesis

Mbio

2022/8/30

SARS-CoV-2 infection produces chronic pulmonary epithelial and immune cell dysfunction with fibrosis in mice

Science translational medicine

2022/7/7

Spatial Transcriptional Profiling of Chronic Pulmonary Disease in a Mouse-Adapted Model of SARS-CoV-2

2022/5

A modified vaccinia Ankara vaccine expressing spike and nucleocapsid protects rhesus macaques against SARS-CoV-2 Delta infection

Science immunology

2022/3/31

Protective efficacy of rhesus adenovirus COVID-19 vaccines against mouse-adapted SARS-CoV-2

Journal of Virology

2021/11/9

Coagulation and wound repair during COVID-19

2021/10/1

Unfolded protein response inhibition reduces Middle East respiratory syndrome coronavirus-induced acute lung injury

Mbio

2021/8/31

SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung

Nature communications

2021/6/11

Common mechanism of SARS-CoV and SARS-CoV-2 pathogenesis across species

bioRxiv

2021/5/14

Genetic regulation of immune homeostatic lung leukocyte populations influences respiratory virus induced disease in collaborative cross mice

The Journal of Immunology

2021/5/1

SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801

Nature

2021/3/18

Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody

Science

2021/2/19

Publisher Correction: A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures

Nature

2021/2

Baseline T cell immune phenotypes predict virologic and disease control upon SARS-CoV infection in Collaborative Cross mice

2020

A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures (vol 586, pg 560, 2020)

NATURE

2021/1/19

See List of Professors in Lisa E. Gralinski University(University of North Carolina at Chapel Hill)